Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Characterization of the Microbiome to Predict Complications in Chronic Kidney Disease and End Stage Kidney Disease Patients

In this protocol, we plan to prospectively recruit subjects with chronic kidney disease or end stage kidney disease on dialysis. We will obtain stool, blood, urine (if possible), and peritoneal fluid (if on peritoneal dialysis) from the subjects on a regular basis and we will correlate whether the microbiome in these biospecimens are associated with and/or predictive of bacteremia and other complications in chronic kidney disease and end stage kidney disease.

Imaging and Pathologic Correlates for Men at Risk of Prostate Cancer

This is a retrospective and prospective study to study the use of MRI prostate imaging and other patient characteristics such as PSA and commercially available assays and its accuracy in predicting the grade and location of prostate cancer during prostate needle biopsy as well as radical prostatectomy for men going onto surgery. 

Pediatric Inflammatory Bowel Disease (IBD) Biobank

This research study is being conducted by Dr. Robbyn Sockolow, MD, the director of Pediatric Gastroenterology and Nutrition at Weill Cornell Medical College (WCM) and Komansky Children’s Hospital, and Dr. David Artis, PhD, the director of the Jill Roberts Institute for IBD at WCM. Their teams are looking for pediatric patients who are undergoing a colonoscopy or intestinal surgery.

Why is the study being done?
We are learning about the factors underlying inflammatory bowel disease with the hope that we may improve the care of pediatric patients. 

Research Registry - Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF-PRO)

The Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF-PRO)  aims to:

  • Collect information regarding the natural history of IPF and healthcare interactions
  • Describe quality of life of IPF participants with patient reported questionnaires
  • Assess the methods of treatment of participants
  • Collect blood specimens for future research projects

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)

CREST-2 is a study for people who have narrowing of their carotid artery without symptoms caused by that artery like small strokes or temporary strokes. Temporary strokes are often called transient ischemic attacks or TIAs. The purpose of this study is to compare intensive medical management alone to intensive medical management plus a procedure to reopen the carotid artery in the neck for treatment of plaque buildup.

Remission without Admission

In 2014, Ralph Hills was diagnosed with acute myeloid leukemia (AML) and his doctors told him to “get your affairs in order." Everything changed when he enrolled in an innovative clinical trial. Learn about the treatment that put his cancer into remission without requiring him to be admitted to the hospital.

There's an App for That

Last year, Apple unveiled a new platform that offers a streamlined way to create mobile applications linked to medical research. The technology, called ResearchKit, lets investigators more easily connect with the people whose diseases they're studying, allowing them to gather feedback on symptoms, as well as data on everything from a patient's weight to the air quality where they live.

Researchers Develop Method to Identify Patient-Specific Drugs for Treating Diabetes

An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease. The research by Weill Cornell Medicine investigators was published Aug. 11 in Cell Stem Cell, and may extend the use of precision medicine to metabolic diseases.

We Are Weill Cornell Medicine: Dr. Olivier Elemento

Computational biologist Dr. Olivier Elemento was just 6 years old when he received his first microscope and computer. Now he is harnessing the power of both to spot patterns and trends in cancer that could help doctors treat the disease — and perhaps even find a cure.